EBOS GROUP LIMITED — Board/Management Information 2019

Aug 20, 2019

==> picture [149 x 44] intentionally omitted <==

21 August 2019

NZX/ASX Code: EBO

Retirement of Mark Waller

EBOS Group announces that Mr Mark Waller has advised the Board that he will retire as a director and Chairman of EBOS Group at the conclusion of the Annual Meeting scheduled for 15 October 2019.

Mr Waller joined EBOS in March 1984 as its Chief Financial Officer before assuming the position of Chief Executive Officer in 1987. At that time, EBOS Group was a small player in the New Zealand healthcare industry, with annual revenues of approximately NZ$8 million, primarily from marketing and distributing surgical and dental supplies under license from manufacturers.

Facing significant pressure from larger competitors and multi-national corporations, Mr Waller sought to create a business that followed customers over their lifetime and drove a culture that attracted some of the best and brightest minds in the industry.

Over the next 27 years, he led the Group on an ambitious yet disciplined growth strategy, overseeing many successful mergers and acquisitions, including the purchase of Symbion in 2013 for $1.1 billion. Under his leadership, EBOS Group grew to become the largest trans-Tasman healthcare and animal care company with revenues in excess of NZ$6 billion.

After handing over the reins as CEO in 2014, Mr Waller remained on the Board before assuming the position of Chairman in 2015.

During his career Mr Waller has received many business accolades including the Chief Executive of the Year Award at the Deloitte 200 Awards in 2011 and the Leadership Award at the INFINZ Industry Awards in 2014. In August 2019, he received the ultimate recognition of his significant contribution to New Zealand business with his induction into the New Zealand Business Hall of Fame.

Mr Waller will depart EBOS Group acknowledged as a warm and personable leader and a pivotal figure who has been central to the Group’s sustained and significant growth in shareholder value.

The Board has elected Liz Coutts as Chair with effect from Mr Waller’s retirement. Ms Coutts has been a director of EBOS Group since 2003 and is currently the Chair of the Audit & Risk Management Committee and a member of the Remuneration Committee. She is also Chair of Ports of Auckland Ltd, Oceania Healthcare Ltd and Skellerup Holdings Limited, Director of Tennis Auckland Region Incorporated and Member, Marsh New Zealand Advisory Board.

Janelle Cain General Counsel EBOS Group Limited

EBOS Group Limited. NZBN 9429031998840 Level 7, 737 Bourke Street, Docklands, Victoria 3008, Australia. Phone: +61 3 9918 5555, Fax: +61 3 9918 5588. www.ebosgroup.com

For further information, please contact: New Zealand Media Australian Media Geoff Senescall James Aanensen Senescallakers PRX +64 21 481 234 +61 410 518 590 Investor Relations Mark Connell Investor Relations Manager EBOS Group Limited +61 402 995 519

About EBOS Group

EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading Australasian animal care brand owner, products marketer and distributor.

EBOS Group Limited. NZBN 9429031998840 Level 7, 737 Bourke Street, Docklands, Victoria 3008, Australia. Phone: +61 3 9918 5555, Fax: +61 3 9918 5588. www.ebosgroup.com